• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.93% Nasdaq Up1.30%

    Allergan Inc. (AGN)

    -NYSE
    207.00 Up 1.25(0.61%) 3:10PM EST - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Allergan Inc.
    2525 Dupont Drive
    Irvine, CA 92612
    United States - Map
    Phone: 714-246-4500
    Fax: 714-246-6987
    Website: http://www.allergan.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Other
    Full Time Employees:11,500

    Business Summary 

    Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company also holds LiRIS Program, which is in Phase II trials for the treatment of interstitial cystitis/bladder pain syndrome. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. The company focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. It has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Allergan Inc.

    Corporate Governance 
    Allergan Inc.’s ISS Governance QuickScore as of Dec 1, 2014 is 9. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 9; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. David E. I. Pyott , 60
    Chairman and Chief Exec. Officer
    3.24M0.00
    Mr. Douglas S. Ingram J.D., Esq., 51
    Pres
    1.91M0.00
    Dr. Scott M. Whitcup M.D., 55
    Chief Scientific Officer and Exec. VP of R&D
    1.16M7.62M
    Mr. Julian S. Gangolli , 56
    Corp. VP and Pres of North America
    933.00K2.96M
    Mr. Jeffrey L. Edwards , 53
    Non-Exec. Officer
    1.16M6.86M
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders